Immune-modulating and anti-inflammatory marine compounds against cancer

Semin Cancer Biol. 2022 May:80:58-72. doi: 10.1016/j.semcancer.2020.02.008. Epub 2020 Feb 15.

Abstract

The recent advances in cancer immunotherapy confirm the crucial role of the immune system in cancer progression and treatment. Chronic inflammation and reduced immune surveillance are both features of the tumor microenvironment. Strategies aimed at reverting pro-tumor inflammation and stimulating the antitumor immune components are being actively searched, and the anticancer effects of many candidate drugs have been linked to their ability to modulate the immune system. Marine organisms constitute a rich reservoir of new bioactive molecules; some of them have already been exploited for pharmaceutical use, whereas many others are undergoing clinical or preclinical investigations for the treatment of different diseases, including cancer. In this review, we will discuss the immune-modulatory properties of marine compounds for their potential use in cancer prevention and treatment and as possible tools in the context of cancer immunotherapy.

Keywords: Anticancer treatment; Chronic inflammation; Immune system; Immunotherapy of cancer; Marine compounds.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Aquatic Organisms
  • Humans
  • Immunotherapy
  • Inflammation / drug therapy
  • Inflammation / prevention & control
  • Neoplasms* / drug therapy
  • Tumor Microenvironment

Substances

  • Anti-Inflammatory Agents